Browsing by Author Simes, Robert John

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 21 to 40 of 182 < previous   next >
Issue DateTitleAuthor(s)Citation
2002Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and establisheed ischaemic heart disease: is it cost effective?Eckermann, Simon; Kirby, Adrienne; Martin, Andrew; Mulray, Sarah; Simes, Robert John; Caleo, Susan; Glasziou, Paul P; Hall, Jane P; Tonkin, Andrew M; White, Harvey D; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Clinical Schools; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreCholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and establisheed ischaemic heart disease: is it cost effective?, Medical Journal of Australia, vol.177,(8),2002,pp 428-434
2002Clinical characteristics and outcome of patients with early(<2h), intermediate (2-4h) and late (>4h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarctionPatel, Anushka; Simes, Robert John; Akhras, F; Ellis, S; Garcia, E; Gibbons, R J; Granger, C; Grines, C L; Grinfeld, L; Jones, W; Ribeiro, E E; Ribichini, F; Weaver, W D; Zijlstra, F; The George Institute for International Health; School of Public Health: NH&MRC Clinical Trials CentreClinical characteristics and outcome of patients with early(<2h), intermediate (2-4h) and late (>4h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction, European Heart Journal, vol.23,(7),2002,pp 550-557
2003Clinical trials research in the new millennium: the International Clinical Trials Symposium, Sydney, 21-23 October 2002Keech, Anthony (Tony); Simes, Robert John; Pike, R; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreClinical trials research in the new millennium: the International Clinical Trials Symposium, Sydney, 21-23 October 2002, Medical Journal of Australia, vol.178,(7),2003,pp 316-317
2008Comparing patients' and clinicians' assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial)Coskinas, Xanthi; Gebski, Val; Simes, Robert John; Smith, Michaella; Sourjina, Tatiana; Stockler, Martin; Ung, Owen; Campbell, Ian; Gill, P Grantley; Kollias, James; Macphee, Avis; Wetzig, Neil R; Young, Leonie; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: SurgeryComparing patients' and clinicians' assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial), Breast Cancer Research and Treatment, vol.Online (117), (1), 2008,pp 1 (99)-11 (109)
2005Comparing patients' and their partners' preferences for adjuvant chemotherapy (ACT) in early breast cancer (EBC)Beith, Jane; Boyle, Frances; Butow, Phyllis; Coates, Alan; Duric, Vlatka; Heritier, Stephane; Sharpe, Louise; Simes, Robert John; Stockler, Martin; Wilcken, Nicholas; Central Clinical School: Medicine; Central Clinical School: Medicine; Psychology; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead)Comparing patients' and their partners' preferences for adjuvant chemotherapy (ACT) in early breast cancer (EBC), Journal of Clinical Oncology (Print), vol.23,(16S),2005,pp 546S-546S
2008Comparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancerButow, Phyllis; Coates, Alan; Duric, Vlatka; Heritier, Stephane; Sharpe, Louise; Simes, Robert John; Stockler, Martin; Beith, Jane M.; Boyle, Frances; Wilcken, Nocholas; Psychology; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; The George Institute for Global Health; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreComparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancer, Patient Education and Counseling, vol.72, 2, 2008,pp 239-245
2010Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized TrialBoland, Amy L.; Boyer, Michael; Gebski, Val; Grimison, Peter; Gurney, Howard; Simes, Robert John; Stockler, Martin; Craft, Paul; Harvey, V; Levi, John; Lewis, Craig; Olver, Ian N; Thomson, Damien; Toner, Guy C.; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreComparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial, Journal of the National Cancer Institute, vol.102, 16, 2010,pp 1253-1262
2006Correction to the FIELD study reportBarter, Philip; Best, James; Keech, Anthony (Tony); Scott, R; Simes, Robert John; Taskinen, M; Central Clinical School: Medicine; Medicine Faculty Office; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: MedicineCorrection to the FIELD study report, The Lancet, vol.368,(9545),2006,pp 1415-N/A
2015Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancerGebski, Val; Lee, Chee Khoon; Mann, Kristy; Simes, Robert John; Wilson, Kate; Bruhn, M; Cunningham, David; Hardingham, Jennifer; Price, Timothy; Robinson, B; Tebbutt, Niall; Townsend, Amanda; van Hazel, Guy; Weickhardt, Andrew; Wrin, Joseph; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreCorrelation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer, British Journal of Cancer, vol.112, 6, 2015,pp 963-970
2014The cost effectiveness of bevacizumab when added to capecitabine, with or without mitomycin-C, in first line treatment of metastatic colorectal cancer: Results from the Australasian phase III MAX studyCarter, Hannah; Howard, Kirsten; Schofield, Deborah; Simes, Robert John; Zannino, Diana; Price, Timothy; Tebbutt, Niall C; Zalcberg, John; Anaesthesia; School of Public Health: Public Health; Pharmacy; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreThe cost effectiveness of bevacizumab when added to capecitabine, with or without mitomycin-C, in first line treatment of metastatic colorectal cancer: Results from the Australasian phase III MAX study, European Journal of Cancer, vol.50, 3, 2014,pp 535-543
2006Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study.Eckermann, Simon; Glasziou, Paul; Kirby, Adrienne; Mulray, Sarah; Simes, Robert John; Denton, Mary; Friedlander, D; Hunt, David; LIPID, S u; Magnus, Paul; Sallaberger, Michele; Tonkin, Andrew; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials Centre; Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreCost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study., American Heart Journal, vol.151,(6),2006,pp 1305-1312
2017Delayed versus Immediate Cord Clamping in Preterm InfantsAskie, Lisa; Brown, Rebecca; Evans, Nicholas; Finlayson, Sarah; Fogarty, Michael; Gebski, Val; Ghadge, Alpana; Hague, Wendy; Isaacs, David; Jeffery, Michele; Keech, Anthony (Tony); Kirby, Adrienne; Kluckow, Martin; Liley, Helen; Morris, Jonathan; Osborn, David; Popat, Himanshu; Robledo, Kristy; Sebastian, Lucille; Simes, Robert John; Tarnow-Mordi, William; Aagaard, K; Abdel-Latif, Mohamed E; Ariff, Shabina; Belfort, M; Chen, Y; Colditz, Paul B.; et al, Various; Pammi, M; Reynolds, G; Sheikh, L; NH&MRC Clinical Trials Centre; School of Public Health: Public Health; Central Clinical School: Obstetrics & Gynaecology; NH&MRC Clinical Trials Centre; Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Childrens Hospital Westmead: Paediatrics & Child Health; Northern Clinical School: Kolling Institute; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Obstetrics & Gynaecology; NH&MRC Clinical Trials Centre; Northern Clinical School: Kolling Institute; Central Clinical School: Obstetrics & Gynaecology; Central Clinical School: Obstetrics & Gynaecology; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreDelayed versus Immediate Cord Clamping in Preterm Infants, New England Journal of Medicine, vol.377, 25, 2017,pp 2445-2455
2003Depression and cardiovascular morbidity and mortality: cause or consequence?Simes, Robert John; Colquhoun, David; North, Fiona M.; Sharples, Katrina J.; Stewart, Ralph A.H.; Tonkin, Andrew M; West, Teena M.; White, Harvey D; School of Public Health: NH&MRC Clinical Trials CentreDepression and cardiovascular morbidity and mortality: cause or consequence?, European Heart Journal, vol.24,(N/A),2003,pp 2027-2037
2009Deriving a Patient-Based Utility Index from a Cancer-Specific Quality of Life QuestionnaireGrimison, Peter; Hudson, Malcolm; Simes, Robert John; Stockler, Martin; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreDeriving a Patient-Based Utility Index from a Cancer-Specific Quality of Life Questionnaire, Value in Health, vol.12, 5,pp 800-807
2007Development and validation of optimally weighted measures of global health-related quality of life (QoL) and utility based on a cancer-specific QoL instrumentGrimison, Peter; Simes, Robert John; Stockler, Martin; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreDevelopment and validation of optimally weighted measures of global health-related quality of life (QoL) and utility based on a cancer-specific QoL instrument, Value in Health, vol.10, 6,pp A226-A227
2005Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary intervention.Simes, Robert John; Bittl, John A; Eikelboom, John; Garg, Jyotsna; Granger, Christopher B; Mehta, Shamir; Serruys, Patrick; Sinnaeve, Peter R; Topol, Eric J; Yusuf, Salim; School of Public Health: NH&MRC Clinical Trials CentreDirect thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary intervention., European Heart Journal (2005), vol.26,(22),2005,pp 2396-403
2006Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer.Beale, Philip; Boyer, Michael; Clarke, Stephen; Simes, Robert John; Stockler, Martin; Tattersall, Martin; Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: MedicineDisarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer., British Journal of Cancer, vol.94,(2),2006,pp 208-212
2011Early Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer.Brown, Christopher; Gebski, Val; Lee, Chee; Lord, Sarah (Sally); Simes, Robert John; Delva, Remy; Donadello, Nicoletta; Friedlander, Michael L.; Georgoulopoulos, Alexander; Mirza, Mansoor Raza; Pignata, Sandro; Pujade-Lauraine, Eric; Schmalfeldt, Barbara; Southier, Philippe; Vergote, Ignace; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEarly Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer., Journal of the National Cancer Institute, vol.103, 17, 2011,pp 1338-1342
2010The Early Prevention of Obesity in CHildren (EPOCH) Collaboration - an Individual Patient Data Prospective Meta-AnalysisAskie, Lisa; Baur, Louise; Rissel, Chris; Simes, Robert John; Voysey, Merryn; Campbell, Karen J.; Daniels, L.; Hesketh, Kylie; Magarey, Anthea M.; Mihrshahi, Seema; Taylor, Barry J.; Taylor, Rachael; Wen, Li-Ming; School of Public Health: NH&MRC Clinical Trials Centre; Children's Hospital Westmead: Paediatrics & Child Health; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreThe Early Prevention of Obesity in CHildren (EPOCH) Collaboration - an Individual Patient Data Prospective Meta-Analysis, BMC Public Health, vol.10, N/A,pp 728-1-728-8
2007Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trialKeech, Anthony (Tony); Merrifield, Alistair; Mitchell, Ronald (Paul); Moffitt, Mireille; O'Connell, Rachel; Simes, Robert John; Tse, D; Williamson, E; Crimet, D. C.; Davis, T. M. E.; D'Emden, MC; Laatikainen, LT; O'Day, J; Summanen, PA; Taskinen, M; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Clinical Ophthal & Eye Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEffect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial, The Lancet, vol.370,(9600),2007,pp 1687-1697